Dr. Monica Benvenuto is a Researcher at the “Saint Camillus International University of Health and Medical Sciences” of Rome. She graduated in Medical Biotechnology at the University of Rome “Tor Vergata” and received a Ph.D. in Molecular Medicine at the University of Rome “Sapienza”. She was a research fellow at the University of Rome “Tor Vergata” for several years. Her research activity is focused on the development of new experimental approaches for the treatment of tumors: cancer immunotherapy and the study of the in vitro and in vivo effects of natural compounds, anticancer vaccines, and intracellular signaling transduction pathways inhibitors on cancer cell growth. She is the author of several publications in international journals of high scientific quality.